跳至主要内容
临床试验/ISRCTN77817048
ISRCTN77817048已完成不适用

Optimising pelvic floor muscle training to improve quality of life outcomes for individuals with progressive multiple sclerosis and incontinence: a feasibility study

orth Bristol NHS Trust0 个研究点目标入组 90 人开始时间: 2015年4月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. 18 years or older, NHS patients
  • 2. Primary or secondary progressive MS diagnosis
  • 3. UI, FI or both for at least three months
  • 4. Participants who complete ICIQ­UI Short Form and report some incontinence (About once a week or less often” to All the time” to item 3 ­ ICIQ-­UI Short Form), and/or,
  • 5. Participants who complete ICIQ-­B and report some incontinence (Most of the time” to Never” to items 9, 10 or 11 ­ ICIQ-­B 04/08)
  • 6. Cognitive capacity to complete assessments and treatment protocol (Mini Mental State Examination >8)
  • 7. Stable disease over previous 3 months
  • 8. Ability to contract pelvic floor muscles (perineometer response >0)
  • 9. Participants taking LUTS medications can participate if they have been taking the medication at a stable dose for at least three months prior to study enrolment
  • 10. Participants taking Loperamide or bowel relaxation medications can participate if they have been taking the medication at a stable dose for at least three months prior to study enrolment

排除标准

  • 1. MS relapse including escalation of symptoms or requiring hospitalization, during the three months prior to the study
  • 2. Introduction of new MS therapies or medications during the three months prior to the study
  • 3. Symptomatic urinary tract infection
  • 4. Indwelling urinary catheter if only reporting urinary incontinence (can be included with catheter if presenting with faecal incontinence for the trial)
  • 5. Pregnancy
  • 6. Vaginal delivery or caesarian section in previous twelve months
  • 7. Pelvic organ prolapse that is visible beyond the intra-­oitus on relaxation or cough.
  • 8. Incontinence surgery if undertaken for presenting symptoms (if presenting with faecal incontinence for the trial and incontinence surgery has been undertaken for urinary cause they can be included, and vice versa)
  • 9. Red flag bowel symptoms such as bleeding or recent unexplained change in bowel habit.

研究者

发起方
orth Bristol NHS Trust

相似试验